Skip to main content
MedTech Europe Updates Regulatory Affairs NewsletterMedTech Europe Updates Regulatory Affairs Newsletter ArchiveRegulatory Affairs NewsletterRegulatory Affairs Newsletter Archive

MedTech Europe quarterly webinar for Partner Trade Associations around the World (Mon, 24 Nov, 3-4 pm CET)

On Monday, 24 Nov 2025 from 15:00 to 16:00 pm CET (Brussels time), MedTech Europe will host its next quarterly webinar regarding the implementation status of the EU In Vitro Diagnostic Medical Devices and Medical Devices Regulations (IVDR and MDR) for its partner medtech trade associations around the world. The webinar will be 60 minutes in duration including a 30-minute Q&A. Due to…
Ben Kemp
November 13, 2025
Industry Newsletters Regulatory Affairs NewsletterIndustry Newsletters Regulatory Affairs Newsletter ArchiveRegulatory Affairs NewsletterRegulatory Affairs Newsletter Archive

Your Due Diligence Requirements Globally – 2025 Deadlines [2 Expert Guides]

From Disclosure To Enforcement: Navigating The World's Emerging Human Rights Due Diligence Regulations Based on our expert webinar, Emerging Human Rights Due Diligence Regulations Across the Globe - this guide establishes the foundational WHY and WHERE of mandatory Due Diligence, covering the global shift: Global Enforcement: The history of HRDD, from the Rana Plaza tragedy to binding law. US Import…
Ben Kemp
November 13, 2025
Industry Newsletters Regulatory Affairs NewsletterIndustry Newsletters Regulatory Affairs Newsletter ArchiveRegulatory Affairs NewsletterRegulatory Affairs Newsletter Archive

EU Network of Comprehensive Cancer Centres reaches key milestone

EU Network of Comprehensive Cancer Centres reaches key milestone The European Network of Comprehensive Cancer Centres (EUnetCCC), a key flagship initiative of Europe’s Beating Cancer Plan, was launched in Paris this week. Supported by €90 million of EU investment under the EU4Heath Programme, the objective of the Network is to support cancer patients in accessing high-quality prevention, diagnosis, treatment and…
Ben Kemp
November 13, 2025
Regulatory Affairs NewsletterRegulatory Affairs Newsletter ArchiveUK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

MHRA Updates (WC 10th Nov)

Rare therapies and UK regulatory considerations Page summary: A paper outlining MHRA’s intentions to make it quicker and easier to get rare disease therapies tested, manufactured and approved in the UK. Change made: First published. Time updated: 7:55am, 2 November 2025 Major change for rare disease treatments on way, signals MHRA Page summary: New paper sets out UK regulator’s intentions…
Ben Kemp
November 13, 2025
Regulatory Affairs NewsletterRegulatory Affairs Newsletter ArchiveUK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

DEFRA Updates (WC 10th Nov)

Lumpy skin disease in Europe Page summary: Preliminary and updated outbreak assessments for lumpy skin disease in Europe. Change made: Added outbreak assessment for lumpy skin disease in Europe, 28 October 2025. Time updated: 3:30pm, 3 November 2025 Foot and mouth disease in North Africa and the Middle East Page summary: Preliminary outbreak assessment of the foot and mouth disease…
Ben Kemp
November 13, 2025
Regulatory Affairs NewsletterRegulatory Affairs Newsletter ArchiveUK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

Department for Business and Trade Updates (WC 10th Nov)

Countering sanctions evasion: guidance for freight and shipping Page summary: For freight forwarders, carriers, hauliers, customs intermediaries, postal and express operators, and other companies facilitating the movement of goods. Change made: First published. Time updated: 12:06pm, 3 November 2025 Service and performance code for export licensing Page summary: Sets out the government’s service delivery objectives, commitments and targets for management…
Ben Kemp
November 13, 2025